POSEIDA THERAPEUTICS INC shareholders Q1 2024

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 90 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

POSEIDA THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 3,596,476$11,472,7583.19%
Aisling Capital Management LP 1,043,267$3,328,0221.13%
Boxer Capital, LLC 4,475,000$14,275,2500.70%
Octagon Capital Advisors LP 736,000$2,347,8400.28%
Atom Investors LP 619,674$1,976,7600.25%
Pentwater Capital Management LP 5,975,000$19,060,2500.20%
MCF Advisors LLC 247,024$788,0080.06%
CANTOR FITZGERALD, L. P. 75,205$239,9040.06%
Artia Global Partners LP 86,002$274,3460.06%
Forefront Analytics, LLC 26,780$85,4290.04%
XTX Topco Ltd 90,650$289,1740.04%
CORNERCAP INVESTMENT COUNSEL INC 79,552$253,7710.04%
Palumbo Wealth Management LLC 26,068$83,1570.04%
Callan Capital, LLC 78,580$250,6700.02%
RBF Capital, LLC 70,171$223,8450.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 830,127$2,648,1050.01%
BLAIR WILLIAM & CO/IL 965,052$3,078,5160.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 143,600$458,0840.01%
Connor, Clark & Lunn Investment Management Ltd. 503,760$1,606,9940.01%
Keystone Financial Group 15,000$47,8500.01%
External links

This page lists POSEIDA THERAPEUTICS INC's shareholders in Q1 2024. To view POSEIDA THERAPEUTICS INC's shareholder history, click here.